| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression A Sreekumar, LM Poisson, TM Rajendiran, AP Khan, Q Cao, J Yu, ... Nature 457 (7231), 910-914, 2009 | 2479 | 2009 |
| Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins A Sreekumar, MK Nyati, S Varambally, TR Barrette, D Ghosh, ... Cancer research 61 (20), 7585-7593, 2001 | 460 | 2001 |
| Induced chromosomal proximity and gene fusions in prostate cancer RS Mani, SA Tomlins, K Callahan, A Ghosh, MK Nyati, S Varambally, ... Science 326 (5957), 1230-1230, 2009 | 448 | 2009 |
| Integration of EGFR inhibitors with radiochemotherapy MK Nyati, MA Morgan, FY Feng, TS Lawrence Nature Reviews Cancer 6 (11), 876-885, 2006 | 421 | 2006 |
| TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer R Banerjee, N Russo, M Liu, V Basrur, E Bellile, N Palanisamy, ... Nature communications 5 (1), 4527, 2014 | 172 | 2014 |
| Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts E Kievit, MK Nyati, E Ng, LD Stegman, J Parsels, BD Ross, A Rehemtulla, ... Cancer research 60 (23), 6649-6655, 2000 | 134 | 2000 |
| Radiosensitization by Pan ErbB Inhibitor CI-1033 in Vitro and in Vivo MK Nyati, D Maheshwari, S Hanasoge, A Sreekumar, SD Rynkiewicz, ... Clinical cancer research 10 (2), 691-700, 2004 | 108 | 2004 |
| Synergistic effects of gemcitabine and gefitinib in the treatment of head and neck carcinoma PY Chun, FY Feng, AM Scheurer, MA Davis, TS Lawrence, MK Nyati Cancer research 66 (2), 981-988, 2006 | 101 | 2006 |
| The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model MK Nyati, Z Symon, E Kievit, KJ Dornfeld, SD Rynkiewicz, BD Ross, ... Gene therapy 9 (13), 844-849, 2002 | 100 | 2002 |
| KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradation S Shukla, US Allam, A Ahsan, G Chen, PM Krishnamurthy, K Marsh, ... Neoplasia 16 (2), 115-W5, 2014 | 92 | 2014 |
| Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumors A Ahsan, SG Ramanand, C Whitehead, SM Hiniker, A Rehemtulla, ... Neoplasia 14 (8), 670-IN1, 2012 | 92 | 2012 |
| The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling S Nyati, K Schinske-Sebolt, S Pitchiaya, K Chekhovskiy, A Chator, ... Science signaling 8 (358), ra1-ra1, 2015 | 86 | 2015 |
| Role of transcriptional corepressor CtBP1 in prostate cancer progression R Wang, IA Asangani, BVSK Chakravarthi, B Ateeq, RJ Lonigro, Q Cao, ... Neoplasia 14 (10), 905-IN8, 2012 | 83 | 2012 |
| Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity FY Feng, S Varambally, SA Tomlins, PY Chun, CA Lopez, X Li, MA Davis, ... Oncogene 26 (23), 3431-3439, 2007 | 82 | 2007 |
| Role of epidermal growth factor receptor degradation in cisplatin-induced cytotoxicity in head and neck cancer A Ahsan, SM Hiniker, SG Ramanand, S Nyati, A Hegde, A Helman, ... Cancer research 70 (7), 2862-2869, 2010 | 80 | 2010 |
| Role of cell cycle in epidermal growth factor receptor inhibitor-mediated radiosensitization A Ahsan, SM Hiniker, MA Davis, TS Lawrence, MK Nyati Cancer research 69 (12), 5108-5114, 2009 | 77 | 2009 |
| Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo FY Feng, CA Lopez, DP Normolle, S Varambally, X Li, PY Chun, ... Clinical cancer research 13 (8), 2512-2518, 2007 | 72 | 2007 |
| High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer MK Nyati, A Sreekumar, S Li, M Zhang, SD Rynkiewicz, AM Chinnaiyan, ... Cancer Research 62 (8), 2337-2342, 2002 | 68 | 2002 |
| Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer A Argiris, AG Duffy, S Kummar, NL Simone, Y Arai, SW Kim, SF Rudy, ... Clinical Cancer Research 17 (17), 5755-5764, 2011 | 67 | 2011 |
| EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection KC Cuneo, MK Nyati, D Ray, TS Lawrence Pharmacology & therapeutics 154, 67-77, 2015 | 65 | 2015 |
